Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Garofalo Health Care SpAMIL:GHC +0.36%86 EV-to-EBIT is 16.73 as of Jul. 24, 2026, which is 8% above its 10-year median of 15.42. GuruFocus rates MIL:GHC with a GF Score™ of 86/100 and a GF Value™ of €6.08 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 469 Healthcare Providers & Services companies, Garofalo Health Care SpA ranks worse than 54.16% on this metric.
The historical rank and industry rank for Garofalo Health Care SpA's EV-to-EBIT or its related term are showing as below:
MIL:GHC'
s EV-to-EBIT Range Over the Past 10 Years
Min: 8.25 Med: 15.42 Max: 156.01
Current: 16.72
During the past 11 years, the highest EV-to-EBIT of Garofalo Health Care SpA was 156.01. The lowest was 8.25. And the median was 15.42.
MIL:GHC's EV-to-EBIT is ranked worse than 54.16% of 469
companies
in the Healthcare Providers & Services industry
Industry Median: 15.87
vs MIL:GHC: 16.72
Garofalo Health Care SpA (MIL:GHC) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Garofalo Health Care SpA's Enterprise Value for the quarter that ended in Mar. 2026 was €626.1 Mil.
Garofalo Health Care SpA's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €42.1 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Garofalo Health Care SpA EV-to-EBIT Related Terms
Garofalo Health Care SpA EV-to-EBIT Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Garofalo Health Care SpA's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Garofalo Health Care SpA EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Garofalo Health Care SpA's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Garofalo Health Care SpA's EV-to-EBIT falls into.
Garofalo Health Care SpA's current Enterprise Value is €704.7 Mil.
Garofalo Health Care SpA's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €42.1 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Garofalo Health Care SpA (MIL:GHC) has a EV-to-EBIT of 16.73 as of Jul. 24, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Garofalo Health Care SpA and its competitors. This is near median its historical median of 15.42. Over the past decade, Garofalo Health Care SpA's EV-to-EBIT has ranged from 8.25 to 156.01. According to the industry distribution chart, Garofalo Health Care SpA ranks #254 out of 469 companies in the Healthcare Providers & Services industry, placing it in the top 54.2%.
Is Garofalo Health Care SpA's EV-to-EBIT too high?
Garofalo Health Care SpA's current EV-to-EBIT of 16.73 is near median its 10-year median of 15.42. Over the past 10 years, this metric has ranged from a low of 8.25 to a high of 156.01. The Healthcare Providers & Services industry median EV-to-EBIT is 15.87. Garofalo Health Care SpA's value of 16.73 is 5.4% above this industry median. Based on the distribution chart, Garofalo Health Care SpA ranks #254 out of 469 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Garofalo Health Care SpA has a GF Score™ of 86/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Garofalo Health Care SpA's EV-to-EBIT compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Garofalo Health Care SpA ranks #254 out of 469 companies for EV-to-EBIT. This places Garofalo Health Care SpA in the lower half of its industry. The industry median EV-to-EBIT is 15.87. Garofalo Health Care SpA's value of 16.73 is 5.4% above this benchmark. Historically, Garofalo Health Care SpA's own EV-to-EBIT has ranged from 8.25 to 156.01 over the past decade. While the company's 10-year median is 15.42 vs. the industry median of 15.87, Garofalo Health Care SpA has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.87, based on 469 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Garofalo Health Care SpA's current EV-to-EBIT of 16.73 is 5.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Garofalo Health Care SpA and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Garofalo Health Care SpA's current EV-to-EBIT is 16.73, which is near median its own 10-year median of 15.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Garofalo Health Care SpA stock overvalued right now?
Based on GuruFocus' analysis, Garofalo Health Care SpA (MIL:GHC) is currently considered Modestly Undervalued. The stock's GF Value™ is €6.08, compared to a current price of €5.50 — trading 9.5% below its estimated fair value. The current EV-to-EBIT is 16.73, which is near median its 10-year median of 15.42 and 5.4% above the Healthcare Providers & Services industry median of 15.87. Garofalo Health Care SpA's overall GF Score™ is 86/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Garofalo Health Care SpA (MIL:GHC), the current EV-to-EBIT is 16.73 as of Jul. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Garofalo Health Care SpA (MIL:GHC) Overvalued in 2026?
Based on GuruFocus' analysis, Garofalo Health Care SpA stock appears to be undervalued.
The current stock price of €5.50 is trading 9.5% below its estimated GF Value™ of €6.08.
GuruFocus considers Garofalo Health Care SpA to be Modestly Undervalued.
Key valuation signals for MIL:GHC:
EV-to-EBIT: 16.73 (near median its 10-year median of 15.42)
GF Value™: €6.08 vs. price of €5.50 (9.5% below fair value)
Industry Position: 5.4% above the Healthcare Providers & Services median (#254 of 469)
No single metric tells the full story. See the MIL:GHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Garofalo Health Care SpA is an Italian accredited private healthcare provider offering a comprehensive range of services across various areas of healthcare through diversified specialties, supported by the use of technologies and qualified personnel. The Group mainly operates in regions of northern and central Italy, which have been selected based on their attractiveness in terms of per capita healthcare spending, above-average per capita income, and well-developed internal transport infrastructure.
86GF Score
Get the complete analysis for MIL:GHC
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:GHC has been successfully added to your 
